Fibronostics will be at the EASL2023 congress in Vienna!
![](https://fibronostics.com/wp-content/uploads/2023/06/NEWS-JUN-2023-EASL-img-1024x691.png)
Fibronostics will be guests at the EASL congress in Vienna, Austria to present ‘NAFLD: Diagnostics and non-invasive assessment’. Join Dr. Mona Munteanu, our Chief Scientific Officer, on 24 June between 09:00 – 17:00 where she will discuss ‘LIVERSTAT, first-line screening tool in at-risk MAFLD patients outperforms the standard-of-care (SOC) FIB-4’ We can’t wait to network with others in the industry, learn […]